Nusinersen, marketed as Spinraza, is a medication used in treating spinal muscular atrophy, a rare neuromuscular disorder. In December 2016, it became the first approved drug used in treating this disorder. From Wikipedia
The deal gives Biogen full rights to ThecaFlex DRx, an implantable port designed to simplify Spinraza dosing.
